PHSE completes acquisition of Air Plus and Bio Pharma Logistics
Milan, 10 july 2023
PHSE, a leading pharmaceutical logistics group, announces that it has completed the acquisition of 80% of Air Plus Srl and Bio Pharma Logistics Srl, Italian companies with a strong specialisation in the temperature-controlled transportation of pharmaceuticals, diagnostic samples and biologicals, especially in the international arena (import and export from Italy). One of the founders, Stefano Cazzulani, will retain 20% of both companies and the management direction of them.
Through this transaction, the PHSE Group, which last year recorded more than €75 million in consolidated revenues, not only strengthens its presence in Italy, but also reinforces its Global Forwarding business unit, dedicated to worldwide shipments of drugs, samples and clinical trials in support of pharmaceutical research.
“We are thrilled to welcome Air plus and Bio Pharma Logistics to our Group with an acquisition that represents a further step in the growth process we have undertaken, not only organically, but also through acquisitions,” said Eddy De Vita, Executive Chairman and major shareholder. This is in fact the fifth extraordinary transaction realised by PHSE since the beginning of 2021.
“We are very satisfied with the Group’s performance, continued De Vita, which has already achieved important milestones in the first half of this year, including the expansion of its international presence to the Spanish market with the opening of the new PHSE Spain subsidiary. “
